MRL Ventures Fund Investor
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Technology:
Drug Discovery
Industry:
Biotechnology, Health Care
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2014-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investor Type:
Corporate Venture Capital, Venture Capital
Investment Stage:
Convertible Note, Early Stage Venture, Seed, Venture
Number Of Exits:
10
Total Funding:
18735034
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-05-23
Last Funding Type:
Series A
Register and Claim Ownership